Harpoon Therapeutics Funding & Investors
South San Francisco, CA
Harpoon Therapeutics is a clinical-stage immunotherapy company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kil...Read more
harpoontx.comTotal Amount Raised: $255,000,000
Harpoon Therapeutics Funding Rounds
Post Ipo Equity
$100,000,000
Post Ipo Equity Investors
Lion Point CapitalSurveyor CapitalCommodore CapitalNew Leaf Venture PartnersABGCormorant Asset ManagementRa Capital ManagementSoleus CapitalInvusK2 HealthVenturesPost Ipo Equity
$25,000,000
Post Ipo Equity Investors
InvusOrbiMed AdvisorsArix BioscienceK2 HealthVenturesNew Leaf Venture PartnersIPO
Unknown
Series C
$70,000,000
Series C Investors
New Leaf Venture PartnersOrbiMed AdvisorsRidgeback Capital ManagementArix BioscienceTaiho VenturesMPM CapitalUBS Asset ManagementLilly Asia VenturesNS Investmentoncology impact fundSeries B
$45,000,000
Series B Investors
Arix BioscienceMPM CapitalNew Leaf Venture PartnersTaiho VenturesUBS Asset ManagementSeries A
$15,000,000
Series A Investors
MPM CapitalUBS Asset Management
Funding info provided by Diffbot.